| Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring N Wenningmann, M Knapp, A Ande, TR Vaidya, S Ait-Oudhia Molecular pharmacology 96 (2), 219-232, 2019 | 281 | 2019 |
| Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway M Jin, A Ande, A Kumar, S Kumar Cell death & disease 4 (3), e554-e554, 2013 | 180 | 2013 |
| Advancing cancer therapy with present and emerging immuno-oncology approaches J Kamta, M Chaar, A Ande, DA Altomare, S Ait-Oudhia Frontiers in oncology 7, 64, 2017 | 83 | 2017 |
| Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes S Kumar, M Jin, A Ande, N Sinha, PS Silverstein, A Kumar Expert opinion on drug metabolism & toxicology 8 (11), 1363-1375, 2012 | 78 | 2012 |
| Effects of cigarette smoke condensate on oxidative stress, apoptotic cell death, and HIV replication in human monocytic cells PSS Rao, A Ande, N Sinha, A Kumar, S Kumar PloS one 11 (5), e0155791, 2016 | 71 | 2016 |
| Effect of mild-to-moderate smoking on viral load, cytokines, oxidative stress, and cytochrome P450 enzymes in HIV-infected individuals A Ande, C McArthur, L Ayuk, C Awasom, PN Achu, A Njinda, N Sinha, ... PloS one 10 (4), e0122402, 2015 | 67 | 2015 |
| Enhanced nicotine metabolism in HIV-1–positive smokers compared with HIV-negative smokers: simultaneous determination of nicotine and its four metabolites in their plasma using … R Earla, A Ande, C McArthur, A Kumar, S Kumar Drug metabolism and disposition 42 (2), 282-293, 2014 | 54 | 2014 |
| Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes A Ande, C McArthur, A Kumar, S Kumar Expert opinion on drug metabolism & toxicology 9 (11), 1453-1464, 2013 | 49 | 2013 |
| An LC–MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes A Ande, R Earla, M Jin, PS Silverstein, AK Mitra, A Kumar, S Kumar Drug and alcohol dependence 125 (1-2), 49-59, 2012 | 40 | 2012 |
| Enhanced oxidative stress by alcohol use in HIV+ patients: possible involvement of cytochrome P450 2E1 and antioxidant enzymes A Ande, N Sinha, PSS Rao, CP McArthur, L Ayuk, PN Achu, A Njinda, ... AIDS research and therapy 12, 1-8, 2015 | 28 | 2015 |
| Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors T Vaidya, J Kamta, M Chaar, A Ande, S Ait-Oudhia Journal of Pharmacokinetics and Pharmacodynamics 45, 401-418, 2018 | 15 | 2018 |
| Combining multiscale experimental and computational systems pharmacological approaches to overcome resistance to HER2-targeted therapy in breast cancer TR Vaidya, A Ande, S Ait-Oudhia Journal of Pharmacology and Experimental Therapeutics 369 (3), 531-545, 2019 | 11 | 2019 |
| Effect of methamphetamine on spectral binding, ligand docking and metabolism of anti-HIV drugs with CYP3A4 AR Nookala, J Li, A Ande, L Wang, NK Vaidya, W Li, S Kumar, A Kumar PLoS One 11 (1), e0146529, 2016 | 11 | 2016 |
| Utility of a novel three-dimensional and dynamic (3DD) cell culture system for PK/PD studies: evaluation of a triple combination therapy at overcoming anti-HER2 treatment … A Ande, TR Vaidya, BN Tran, M Vicchiarelli, AN Brown, S Ait-Oudhia Frontiers in Pharmacology 9, 403, 2018 | 9 | 2018 |
| Multiscale systems pharmacological analysis of everolimus action in hepatocellular carcinoma A Ande, M Chaar, S Ait-Oudhia Journal of Pharmacokinetics and Pharmacodynamics 45, 607-620, 2018 | 5 | 2018 |
| Alcohol and smoking mediated oxidative stress in organ toxicities: Role of Cytochrome P450 systems A Ande, K McFarlin, S Kumar Mini-Reviews in Organic Chemistry 10 (4), 384-392, 2013 | 2 | 2013 |
| Cytochrome P450 enzymes and oxidative stress in tobacco/nicotine mediated HIV pathogenesis A Ande University of Missouri-Kansas City, 2016 | 1 | 2016 |
| Effects of cigarette smoke condensate on HIV pathogenesis PSS Rao, A Ande, N Midde, S Kumar JOURNAL OF NEUROIMMUNE PHARMACOLOGY 10, S94-S95, 2015 | 1 | 2015 |
| Efficacy of Dual HER‐2 and CDK‐4/6 Signaling Blockade at Overcoming Primary HER2 Therapy Resistance in Breast Cancer Y Franco, L Perez, H Mody, A Ande, B Fleisher, S Ait‐Oudhia The FASEB Journal 33 (S1), 815.2-815.2, 2019 | | 2019 |
| SYSTEMS PHARMACOLOGICAL ANALYSIS OF A TUMOR PRIMING COMBINATION THERAPY TO OVERCOME HER2 AND MTOR THERAPIES RESISTANCE IN BREAST CANCER. T Vaidya, A Ande, B Nguyen Tran, A Brown, S Ait-Oudhia CLINICAL PHARMACOLOGY & THERAPEUTICS 103, S10-S10, 2018 | | 2018 |
